Evidence mapPaperPMID 42597739Full record

ReviewNeuroscience applied2026

Mental health and gut-brain crosstalk: implications for depression and Alzheimer's disease.

Kalliopi Skourti, Filippos Katsaitis, Pavlina Pavlidi, Maria Anesti, Jihane Balla, Antonios Emvalomatis, Nikolaos Kokras, Christina Dalla, Ioannis Sotiropoulos

Abstract readReview
In one paragraph

Review in Neuroscience applied, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kalliopi SkourtiLaboratory of Brain Exosomes and Pathology - ExoBrain, Institute of Biosciences & Applications, National Center for Scientific Research (NCSR) "Demokritos", Athens, Greece.
Filippos KatsaitisLaboratory of Brain Exosomes and Pathology - ExoBrain, Institute of Biosciences & Applications, National Center for Scientific Research (NCSR) "Demokritos", Athens, Greece.
Pavlina PavlidiDepartment of Pharmacology, School of Medicine, National and Kapodistrian University of Athens, Greece.
Maria AnestiLaboratory of Brain Exosomes and Pathology - ExoBrain, Institute of Biosciences & Applications, National Center for Scientific Research (NCSR) "Demokritos", Athens, Greece.
Jihane BallaLaboratory of Brain Exosomes and Pathology - ExoBrain, Institute of Biosciences & Applications, National Center for Scientific Research (NCSR) "Demokritos", Athens, Greece.
Antonios EmvalomatisSouroti Ltd, Thessaloniki, Greece.
Nikolaos KokrasFirst Department of Psychiatry, Eginition Hospital, School of Medicine, National and Kapodistrian University of Athens, Greece.
Christina Dalla2nd Department of Obstetrics - Gynecology, Aretaieio Hospital, School of Medicine, National and Kapodistrian University of Athens, Greece.
Ioannis SotiropoulosLaboratory of Brain Exosomes and Pathology - ExoBrain, Institute of Biosciences & Applications, National Center for Scientific Research (NCSR) "Demokritos", Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain health and mental health disorders are increasingly becoming an essential priority for modern societies as they affect different parameters of life, such as brain health, quality of life, and productivity with a heavy societal and economic burden. Among mental health disorders, depression and Alzheimer disease (AD) have the higher impact on mental health globally as they are highly prevalent, cause long-term cognitive and mood deficits while they are deeply interconnected, with chronic stress raising as a risk factor and potential link between both disorders. This review focuses on the gut-brain axis, a bidirectional communication network that links the gut microbiome with the central nervous system, and its role in brain malfunction and pathology related to stress, depression and AD. This intricate gut-brain crosstalk is orchestrated through top-down and bottom-up mechanisms implicating the HPA axis, the enteric nervous system as well as gut microbiota-derived metabolites, neurotransmitters, epigenetic processes and extracellular vesicles/exosomes that can contribute to depression and AD. The current work provides a comprehensive summary of evidence linking gut microbial alterations to these brain pathologies, with particular focus on lifestyle and nutrition (e.g. food, water) as critical regulators. Lastly, we explore the therapeutic potential of microbiome-targeted interventions including pro/pre/post-biotics, and trace elements (e.g. lithium and silicon). Overall, this review highlights the potential of microbiome-centered strategies as novel interventions to support mental health and wellbeing.

Indexed as

Alzheimer's diseaseChronic stressDepressionExtracellular vesiclesGut-brain axisMental healthMicrobiomeModern lifestyleNutrition

Identifiers

PMID42597739
PMCPMC13470543

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.